STL to serve up unified payments

Published 24-NOV-2015 11:22 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Stargroup (ASX:STL) has done a deal to potentially add 50,000 customers into the book and simplify payments for a key market sector.

It told its shareholders in a pre-open release that it had inked a technology development agreement with both Anthem Software and Claim Co Group.

The aim of the deal will be to develop a software channel and get STL’s EFTPOS devices into Anthem’s business customer network.

Anthem is an ‘electronic data interchange’ (EDI) and supply chain software vendor with more than 50,000 users of its software across Australia and New Zealand.

One of Anthem’s key customers is Capricorn Society Limited, a member-based organisation which uses Anthem’s back end to process more than $1.4 billion of member purchases via its EDI network.

Having overseen the transfer of data from Xero and MYOB to SAP and Microsoft respectively, Anthem is considered a heavy hitter in the financial tech space.

Meanwhile Claim Co Group are a mobile and cloud software developer who are best known for developing Zimble, a system to allow business to manage returns.

What they’ll all be getting up to

The three parties will work together to develop a closed network EDI via an EFTPOS platform, which STL will provide.

STL is hoping the resulting tech will allow it to roll out a bulk supply of EFTPOS solutions to buying groups, debtor financers, franchise organisations and to existing Anthem customers.

The upshot is that the whole chain will be unified.

At the moment, a business uses the Anthem system to order supplies from a supplier, with the Anthem gateway used to process the payment and the goods and services are provided to the business from the supplier after the payment is settled.

However, the business then needs to ultimately get payment from the customer for those goods and services and this uses a separate EFTPOS transaction to process payments.

But the vision is for a unified system where transactions from business, supplier, and customer use an EFTPOS interface to keep things in the one place.

Under the tech the trio is developing, the business will be able to order goods and services from suppliers via an EFTPOS interface, and then the customer will be able to pay for the goods or services using the same system.

The planned payments system

The planned payments system

It means there aren’t two separate transaction chains happening for what is essentially the same end service.

Ultimately, once the system has been worked out STL is aiming to roll it out to Anthem’s 50,000 user base, and has even at this early stage fielded enquiries about the plan.

“This is a significant agreement for the group and the development of the IP is likely to be demanded by other member organisations and we are already fielding further enquiries,” STL CEO Todd Zani said.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X